Loading organizations...
§ Private Profile · 1355 Market St #488, San Francisco, California, United States
Melon Health is a technology company.
Melon Health delivers a digital platform designed for chronic disease prevention and management, including mental health support. The company provides online resources and communities, enabling users to self-manage their health journeys. Their approach leverages digital tools to connect patients with information and peer support, fostering engagement in their own care.
The company was founded in 2012 by Siobhan Bulfin. Bulfin's insight stemmed from the need for accessible and empowering tools for individuals navigating long-term health conditions. Her vision was to create digital ecosystems that facilitate patient education and self-management, addressing gaps in traditional healthcare delivery.
Melon Health primarily serves individuals coping with chronic illnesses, such as cancer patients, and those seeking mental health support. The platform aims to empower these users by offering structured digital programs and community interaction. The long-term vision is to broaden access to comprehensive digital health management, enabling a proactive and supported approach to chronic care.
Melon Health has raised $3.4M across 2 funding rounds.
Melon Health has raised $3.4M in total across 2 funding rounds.
Melon Health has raised $3.4M in total across 2 funding rounds.
Melon Health's investors include Lance Wiggs, Chris Simcock, K1W1, Firebrand Ventures.
Melon Health has raised $3.4M across 2 funding rounds. Most recently, it raised $3.3M Series B in November 2018.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 11, 2018 | $3.3M Series B | Lance Wiggs | Chris Simcock, K1W1 | Announced |
| Mar 1, 2015 | $120K Seed | — | Firebrand Ventures | Announced |
Melon Health is a digital health technology company that builds a platform enabling insurers, healthcare providers, and employers to prescribe curated, evidence-based wellness interventions to end consumers.[1][2] It combines behavioral science, data analytics, and design to deliver human-supported digital solutions, such as diabetes prevention and management tools that provide customized insights into health trends and behavior impacts.[1][5] The platform targets chronic condition management and workplace wellness, solving accessibility barriers in healthcare by offering scalable, tech-enabled prescriptions for better user engagement and outcomes.[2][5]
Melon Health's roots trace back to at least 2011, when a different entity named Melon—co-founded by undergraduates Arye Barnehama and Laura Michelle Berman at Pomona College—developed a smart headband for measuring brain activity via electroencephalogram to gauge focus, stress, and fatigue.[3] This early wearable startup, based in Los Angeles, gained traction with customers like augmented reality firm Daqri, which acquired it in 2015 to integrate neuroinformatics into workplace safety helmets, marking a pivot toward enterprise health monitoring.[3] The current Melon Health appears to have evolved into a broader digital platform, focusing on wellness interventions without direct ties to the acquired hardware in available records, emphasizing software for behavioral health.[1][2]
(Note: Distinct from unrelated entities like the 2015-acquired wearable Melon or Corporate Traveler's SME travel platform.[3][4])
Melon Health rides the digital therapeutics trend, where software-as-a-medical-device addresses chronic diseases like diabetes amid rising healthcare costs and demand for preventive care.[5] Timing aligns with post-pandemic shifts toward remote wellness, as employers and insurers seek scalable tools to reduce claims—market forces like aging populations and AI-driven personalization favor platforms like this.[2] It influences the ecosystem by enabling B2B prescription models, bridging traditional healthcare with tech to boost adoption of evidence-based digital interventions.[1]
Melon Health is positioned for growth in the expanding $100B+ digital health market, with potential to deepen diabetes and wellness offerings via AI-enhanced personalization. Upcoming trends like integrated payer-provider ecosystems and regulatory nods for digital therapeutics could accelerate partnerships. Its influence may evolve toward enterprise dominance, humanizing tech-driven health at scale—echoing its origins in innovative monitoring to now empower proactive care.